Invention Grant
- Patent Title: 6-aminoisoquinoline compounds
-
Application No.: US15178174Application Date: 2016-06-09
-
Publication No.: US09890123B2Publication Date: 2018-02-13
- Inventor: Mitchell A. deLong , Susan M. Royalty , Jill Marie Sturdivant , Geoffrey Richard Heintzelman
- Applicant: Aerie Pharmaceuticals, Inc.
- Applicant Address: US CA Irvine
- Assignee: Aerie Pharmaceuticals, Inc.
- Current Assignee: Aerie Pharmaceuticals, Inc.
- Current Assignee Address: US CA Irvine
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; Benjamin D. Heuberger
- Main IPC: C07D401/12
- IPC: C07D401/12 ; C07D217/04 ; A61K31/47 ; C07D217/02 ; C07D215/38 ; C07D405/12 ; C07D409/12 ; C07D417/12
Abstract:
6-Amino isoquinoline compounds are provided that influence, inhibit or reduce the action of a kinase. Pharmaceutical compositions including therapeutically effective amounts of the 6-aminoisoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, obesity and glaucoma are also provided.
Public/Granted literature
- US20160280656A1 6-AMINOISOQUINOLINE COMPOUNDS Public/Granted day:2016-09-29
Information query
